With the backing of venture capital and well-known tech investors, Synapticure seeks to fill in the gaps in care and research for those with amyotrophic lateral sclerosis.
Posted inBusiness
Rethinking Care After an A.L.S. Diagnosis
With the backing of venture capital and well-known tech investors, Synapticure seeks to fill in the gaps in care and research for those with amyotrophic lateral sclerosis.